By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – New England Biolabs said after the close of the market Tuesday that it has inked two new distribution agreements with Bioke and Imperial Life Sciences.

Bioke, a Dutch firm that sells reagents for signal transduction, cell culture, and molecular biology applications, serves markets in the Netherlands, Belgium, and Luxembourg. ILS supplies reagents for genomics, proteomics, cell biology, and imaging applications in India.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.